Gil McGowan, President of The Benefits Alliance Group is in attendance today at the Advocis Symposium at the Ritz Carlton. Stop by our booth to find out about the benefits of membership, and more importantly, what we provide to our clients.
Only one-third of Canadian employers feel prepared for the impending legalization of cannabis, according to a new survey produced by Mercer Canada. A total of 366 Canadian employers and more than 1,000 employees, found another third feels somewhat prepared and 27 per...
Canada’s first major biosimilar drug appears to be having a rough start in the private group insurance industry. Meanwhile, it looks like much smoother sailing for public drug plans, which are going ahead with preferred listing status for Inflectra based on a price...
A Quebec employer recently boasted about its unconventional hiring policy – the company has never hired a “smoker” in its 30 years as a business, and its proud of this stance. News like this is mildly shocking in Canada, where the idea of health outcomes, personal...
The rise of ‘generic’ biologics should mean cost savings for employer drug plans Most of us are familiar with the difference between brand-name drugs and their generic equivalents. Basically, the generics are “bio-equivalent” to the brand names and are, for all...